EP Patent

EP3777853A1 — Mirabegron composition and uses thereof

Assigned to Biohorm SL · Expires 2021-02-17 · 5y expired

What this patent protects

Novel Mirabegron composition comprising: Mirabegron or a pharmaceutical salt thereof; HPMC; and MCC. The combination of HPMC and MCC provides for a controlled release of Mirabegron.

USPTO Abstract

Novel Mirabegron composition comprising: Mirabegron or a pharmaceutical salt thereof; HPMC; and MCC. The combination of HPMC and MCC provides for a controlled release of Mirabegron.

Drugs covered by this patent

Patent Metadata

Patent number
EP3777853A1
Jurisdiction
EP
Classification
—
Expires
2021-02-17
Drug substance claim
No
Drug product claim
No
Assignee
Biohorm SL
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.